Northern Trust’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.2K | Hold |
28,601
| – | – | ﹤0.01% | 4126 |
|
|
2025
Q1 | $58.6K | Buy |
+28,601
| New | +$58.6K | ﹤0.01% | 4211 |
|
|
2024
Q2 | – | Sell |
-7,500
| Closed | -$35.4K | – | 4452 |
|
|
2024
Q1 | $35.4K | Hold |
7,500
| – | – | ﹤0.01% | 4274 |
|
|
2023
Q4 | $34.5K | Hold |
7,500
| – | – | ﹤0.01% | 4296 |
|
|
2023
Q3 | $19.5K | Hold |
7,500
| – | – | ﹤0.01% | 4335 |
|
|
2023
Q2 | $36.3K | Buy |
7,500
+376
| +5% | +$1.82K | ﹤0.01% | 4292 |
|
|
2023
Q1 | $47K | Buy |
7,124
+1,264
| +22% | +$8.33K | ﹤0.01% | 4282 |
|
|
2022
Q4 | $65K | Hold |
5,860
| – | – | ﹤0.01% | 4216 |
|
|
2022
Q3 | $43K | Hold |
5,860
| – | – | ﹤0.01% | 4365 |
|
|
2022
Q2 | $35K | Hold |
5,860
| – | – | ﹤0.01% | 4508 |
|
|
2022
Q1 | $144K | Buy |
5,860
+2,232
| +62% | +$54.8K | ﹤0.01% | 4238 |
|
|
2021
Q4 | $173K | Buy |
+3,628
| New | +$173K | ﹤0.01% | 4247 |
|
|
2021
Q3 | – | Sell |
-13,063
| Closed | -$1.52M | – | 4719 |
|
|
2021
Q2 | $1.52M | Buy |
+13,063
| New | +$1.52M | ﹤0.01% | 3432 |
|